Laxmi Organic Q1 FY27 Revenue Up 40% YoY

The document is a regulatory disclosure and transcript for an Investor & Analyst Meet held to discuss the company's performance for the quarter ended June 30, 2026 (Q1 FY27).
The event was hosted by Strategic Growth Advisors and took place on July 30, 2026, at 2:00 PM IST via a conference call through dial-in.
The stated purpose was to discuss Q1 FY27 results and provide a business update.
Management participants were Dr. Rajan Venkatesh (Managing Director and Chief Executive Officer) and Mr. Amit Jain (Chief Financial Officer).
The company explicitly stated that no Unpublished Price Sensitive Information (UPSI) was shared or discussed during the meeting.
A transcript of the earnings call was enclosed with the disclosure and is also referenced as being available on the stock exchanges, with an audio recording uploaded on July 30, 2026, serving as the definitive record in case of any discrepancy.

Financial Performance for Q1 FY27:

Revenue: Stood at INR 9,683 million, growing 40% year-on-year and 32% sequentially.
EBITDA: Was INR 1,143 million, representing a growth of 272% year-on-year and 113% sequentially.
The growth was driven by a mix of volume growth and higher price realization, aided by supply chain agility and procurement efficiencies.
Net Working Capital: Increased during the quarter due to efforts to secure procurement efficiencies and ensure timely availability of key raw materials amidst volatility. This is expected to normalize over time.
Debt: Term debt has peaked at approximately INR 6,100 million as the Dahej capex cycle nears completion. The company maintains a healthy net debt-to-equity ratio of ~0.3x.

Business Unit Performance:

Specialty Business: Revenue stood at INR 2,418 million, growing 17% year-on-year and 13% sequentially.
Essentials Business: Revenue stood at INR 7,265 million, growing 50% year-on-year and 39% sequentially, supported by double-digit volume growth. The segment delivered an EBITDA margin of 11-12% for the quarter.

Project Updates:

Dahej Project (Phase 2): Mechanical completion, stabilization, and customer qualification are on track for Q2 and Q3 FY27, respectively. Ramp-up is expected in Q4 FY27.
Capex: Full-year FY27 capex estimate is between INR 125 crores to INR 150 crores. 85% of the capex for Phase 2 will be capitalized during Q2 FY27.
Depreciation: An incremental depreciation of approximately INR 7-7.5 crores per quarter is expected post-capitalization of Phase 2.
Project Vaayu (Hitachi): Mechanical completion is anticipated in early Q3 FY27, with revenue contribution expected in FY28.
Site 1 Turnaround: A planned scheduled turnaround was safely concluded in May 2026.

Management Commentary on Markets:

The macro environment was characterized by unpredictability and volatility due to the West Asia crisis and a typhoon in South China, causing significant disruptions in logistics and feedstock prices.
Key raw materials like acetic acid and methanol saw price spikes of nearly 200% from March levels, though some moderation was seen towards the end of May and June.
Demand across key segments (Pharma, Agro, Pigments, Industrial Solutions) was described as broadly stable or showing positive momentum, though customer buying behavior was cautious and varied due to feedstock price gyrations.

The disclosure included an enclosure: the transcript of the Q1 FY27 Earnings Conference Call.
The transcript contained detailed financial data and management commentary, as summarized above.
The document is a standard compliance filing under SEBI LODR Regulations (Regulation 30 read with Schedule III).